Published in Ann N Y Acad Sci on July 21, 1995
ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics (1999) 21.85
Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature (1988) 7.61
Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J Virol (1985) 4.76
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J (1987) 4.56
The atomic structure of the bluetongue virus core. Nature (1998) 4.27
A mechanism for initiating RNA-dependent RNA polymerization. Nature (2001) 3.99
Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. J Mol Biol (1979) 3.88
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature (1997) 3.75
PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell (1996) 3.60
Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature (1987) 3.31
Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci U S A (1998) 3.27
Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol (1996) 3.12
Crystal structure at 2.8 A resolution of a soluble form of the cell adhesion molecule CD2. Nature (1992) 2.76
Structure of tumour necrosis factor. Nature (1989) 2.62
Crystal structure of SIV matrix antigen and implications for virus assembly. Nature (1995) 2.59
Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J (1984) 2.47
Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature (1997) 2.41
Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol (1988) 2.37
The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol (1997) 2.36
Structure and dimerization of a soluble form of B7-1. Immunity (2000) 2.33
Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. J Med Chem (1996) 2.29
The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J (1999) 2.28
The molecular structure of cell adhesion molecules. Annu Rev Biochem (1997) 2.18
Structural changes in glycogen phosphorylase induced by phosphorylation. Nature (1988) 2.16
Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron (1998) 2.11
Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell (1990) 2.10
The crystal structure of plasma gelsolin: implications for actin severing, capping, and nucleation. Cell (1997) 2.10
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. Antimicrob Agents Chemother (1999) 2.08
Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development (1997) 2.07
Most highly repeated dispersed DNA families in the mouse genome. Mol Cell Biol (1984) 2.04
Fibroblast growth factors induce additional limb development from the flank of chick embryos. Cell (1995) 2.01
Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development (1999) 1.98
Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat Struct Biol (1999) 1.88
Tick histamine-binding proteins: isolation, cloning, and three-dimensional structure. Mol Cell (1999) 1.88
Crystal structure of the N-terminal domain of sialoadhesin in complex with 3' sialyllactose at 1.85 A resolution. Mol Cell (1998) 1.86
Crystal structure of a heparin- and integrin-binding segment of human fibronectin. EMBO J (1999) 1.84
The highly ordered double-stranded RNA genome of bluetongue virus revealed by crystallography. Cell (1999) 1.84
Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet (1998) 1.83
Abnormal gastrointestinal development in PDGF-A and PDGFR-(alpha) deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus morphogenesis. Development (2000) 1.82
Functions of fibroblast growth factors and their receptors. Curr Biol (1995) 1.70
Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem (1996) 1.69
Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature (1994) 1.67
Gene polymorphism in Netherton and common atopic disease. Nat Genet (2001) 1.66
Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro. J Virol (1997) 1.65
Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase. Structure (2000) 1.60
Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc Natl Acad Sci U S A (2002) 1.60
Catalysis in the crystal: synchrotron radiation studies with glycogen phosphorylase b. EMBO J (1987) 1.60
Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 A resolution. Nature (1995) 1.55
Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med (2001) 1.55
Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor. Proc Natl Acad Sci U S A (1997) 1.55
Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J Biol Chem (1999) 1.50
High-throughput sample handling and data collection at synchrotrons: embedding the ESRF into the high-throughput gene-to-structure pipeline. Acta Crystallogr D Biol Crystallogr (2006) 1.50
Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility. FASEB J (2004) 1.46
Receptor recognition by gp130 cytokines. EMBO J (2000) 1.46
Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution. Structure (1994) 1.44
Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice. Gut (2003) 1.44
Crystal structure of the extracellular region of human tissue factor. Nature (1994) 1.43
Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors. J Mol Biol (2001) 1.42
Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. J Biol Chem (1997) 1.41
First steps towards effective methods in exploiting high-throughput technologies for the determination of human protein structures of high biomedical value. Acta Crystallogr D Biol Crystallogr (2006) 1.40
An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity (1996) 1.38
Evidence for the role of His-142 of protein 1C in the acid-induced disassembly of foot-and-mouth disease virus capsids. J Gen Virol (1999) 1.38
Refined structure of baboon alpha-lactalbumin at 1.7 A resolution. Comparison with C-type lysozyme. J Mol Biol (1989) 1.38
Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants. J Med Chem (1999) 1.36
Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med (1996) 1.36
Translocation portals for the substrates and products of a viral transcription complex: the bluetongue virus core. EMBO J (2001) 1.35
The structure of a cypovirus and the functional organization of dsRNA viruses. Nat Struct Biol (1999) 1.35
Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development (1997) 1.34
Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. J Biol Chem (2000) 1.34
Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Genes Dev (1990) 1.32
Characterization of the sialic acid-binding site in sialoadhesin by site-directed mutagenesis. J Biol Chem (1996) 1.32
Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum (2001) 1.31
Leukemia inhibitory factor determines the growth status of injured adult sensory neurons. J Neurosci (2001) 1.30
Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J Immunol (1991) 1.30
The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell (1994) 1.29
The human low affinity Fcgamma receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties. J Biol Chem (2001) 1.28
Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity (1996) 1.27
Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids. J Virol (1995) 1.27
Crystal structure of a berenil-dodecanucleotide complex: the role of water in sequence-specific ligand binding. EMBO J (1990) 1.26
Isolated Regional Perfusion in Treatment of Malignant Disease. Br Med J (1962) 1.26